MDXG
What one share of MiMedx Group holds
Surgical and Medical Instruments and Apparatus
MIMEDX is a pioneer and leader focused on helping humans heal. With nearly two decades of helping clinicians manage chronic and other hard-to-heal wounds, MIMEDX provides a leading portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare.
MiMedx Group’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $2.38 |
|---|---|
| Profit | $0.04 |
| Cash and investments | $0.93 |
| Debt | $0.12 |
| Book value | $1.48 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $1.97 | $0.00 | — | $0.21 | — | $0.44 |
| 2017 | $2.77 | $0.56 | — | $0.54 | — | $0.67 |
| 2018 | $3.40 | −$0.28 | — | $0.34 | — | $0.46 |
| 2019 | $2.80 | −$0.24 | — | −$0.37 | — | $0.31 |
| 2020 | $2.29 | −$0.77 | — | −$0.28 | — | −$0.00 |
| 2021 | $2.19 | −$0.15 | $0.03 | −$0.05 | — | $0.00 |
| 2022 | $2.37 | −$0.33 | $0.01 | −$0.17 | — | −$0.16 |
| 2023 | $2.20 | $0.37 | $0.01 | $0.17 | — | $0.98 |
| 2024 | $2.34 | $0.28 | — | $0.44 | — | $1.31 |
| 2025 | $2.80 | $0.32 | — | $0.49 | — | $1.73 |